GlassScriptPhysician profile
Aaron C Barasch
NPI 1427585629
$5,515.86
in general payments reported to CMS, 2019-2025
39 companies · $1,807 in 2025
The $1,807 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $331 · 2022: $702 · 2023: $1,024 · 2024: $1,653 · 2025: $1,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,483.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,531.64 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $626.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $423.76 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.08 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Amgen INC. | $295.37 | 2021-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $292.75 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $286.03 | 2023-2025 | Xarelto, Spravato |
| Glaxosmithkline, LLC. | $271.77 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Cequr Corporation | $131.07 | 2023-2025 | Cequr Simplicity |
| Pfizer INC. | $102.68 | 2021-2025 | |
| Exact Sciences Corporation | $94.20 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $93.80 | 2022-2025 | |
| Abbott Laboratories | $91.18 | 2021-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $87.33 | 2024-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $86.15 | 2024-2025 | Eliquis |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Barasch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.